Praxis precision medicines to participate in upcoming fireside chat

Boston, aug. 05, 2025 (globe newswire) -- praxis precision medicines , inc. (nasdaq: prax), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (cns) disorders characterized by neuronal excitation-inhibition imbalance, today announced that ceo marcio souza will be participating a virtual fireside chat hosted by piper sandler senior research analyst yasmin rahini on august 7, 2025 at 11:00amest.
PRAX Ratings Summary
PRAX Quant Ranking